ACJK, Inc. v. AETNA HEALTH MANAGEMENT, LLC

CourtUnited States Bankruptcy Court, S.D. Illinois
DecidedFebruary 23, 2026
Docket25-03000
StatusUnknown

This text of ACJK, Inc. v. AETNA HEALTH MANAGEMENT, LLC (ACJK, Inc. v. AETNA HEALTH MANAGEMENT, LLC) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, S.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
ACJK, Inc. v. AETNA HEALTH MANAGEMENT, LLC, (Ill. 2026).

Opinion

UNITED STATES BANKRUPTCY COURT

SOUTHERN DISTRICT OF ILLINOIS

In Re ) ) Case No. 23-30045 ACJK, Inc., ) ) Chapter 11 Debtor. ) ) ACJK, Inc., ) ) Plaintiff, ) v. ) Adv. No. 25-03000 ) AETNA HEALTH ) MANAGEMENT, LLC, ) ) Defendant. ) ___________________________________ ) ) In Re ) ) Case No. 23-30045 ACJK, Inc., ) ) Chapter 11 Debtor. ) ) ACJK, Inc. ) ) Plaintiff, ) v. ) Adv. No. 25-03008 ) CVS HEALTH CORPORATION f/k/a ) CVS CAREMARK CORPORATION ) f/k/a CAREMARK PCS, LLC, ) ) Defendant. )

O P I N I O N

Before the Court are motions to dismiss complaint and compel arbitration filed by the defendants in two separate adversary proceedings commenced by the debtor in the same underlying bankruptcy case. For the reasons set forth herein, the motions to dismiss and compel arbitration will be denied and orders will be accordingly entered in each proceeding.

I. Factual Background ACJK, Inc. (“Debtor”), a corporation that operated a pharmacy in Granite City, Illinois, commenced its voluntary Chapter 11 case on January 30, 2023, by filing a bare-bones petition. The Debtor’s schedules and other required documents were filed a month later. On Schedule D: Creditors Who Have Claims Secured by Property, the Debtor listed Aetna Health Management, LLC (“Aetna”), Caremark PCS, LLC, and others as holders of claims in unknown amounts secured by the pharmacy’s accounts receivable valued at $228,800. The debts

were marked by the Debtor as being “disputed.” Among the assets listed on Schedule A/B, the Debtor identified potential causes of action for breach of contract and misrepresentation against Aetna, Caremark, and others of unknown values. On its Statement of Financial Affairs, the Debtor identified Aetna and Caremark as recipients of prepetition transfers in unknown amounts described as “offset DIR fees from Debtor’s accounts receivable.” Aetna and Caremark were similarly identified as having set off debts owed to them by taking unknown amounts from the Debtor’s financial account without permission.

Neither entity filed a proof of claim in the case. The Debtor’s Second Amended Chapter 11 Plan was confirmed on March 5, 2024. The plan defined “DIR Fees” as “pharmaceutical-related expenses deducted from Debtor’s gross sale proceeds by Pharmacy Benefit Managers (PBM’s), including” Aetna and Caremark. The plan was to be implemented in part through a litigation fund comprised of proceeds that might be obtained in pursuing causes of action for the benefit of creditors against the PBMs in relation

to DIR fees collected. On January 29, 2025, the Debtor commenced an adversary proceeding against Aetna, CVS, and several other entities asserting causes of action against each for unauthorized postpetition transfers and constructively fraudulent prepetition transfers under federal and state law based on DIR fees deducted from the Debtor’s accounts receivable in the months and years surrounding the petition date.1 In an order entered February 13, 2025, the Judge previously assigned to the proceeding found that, among other deficiencies, the complaint

impermissibly joined defendants in the same cause of action for what appeared to be separate and distinct transactions or occurrences and directed the Debtor to file separate adversary complaints against each defendant within 21 days. After an initial motion to reconsider was denied, the Debtor filed another document labeled as a motion to reconsider or for clarification, asserting that it had a right to file an amended complaint as a matter of course through which it hoped to cure any issues. Consistent with that position, the Debtor filed a first amended complaint which asserted essentially the same causes of action against

the same defendants. Several named defendants objected and asked the Court

1 The complaint identified CVS as “CVS Health Corporation f/k/a CVS Caremark Corporation f/k/a Caremark PCS, LLC.” The Motion to Dismiss and to Compel Arbitration in adversary case no. 25-03008 was filed by CaremarkPCS Health, LLC asserting that it was the only entity served with summons and that the Motion to Dismiss and to Compel Arbitration was filed only on its behalf. Nevertheless, the amended brief in support of the Motion contends that the arbitration agreement at issue applies equally to CVS Health Corporation as the ultimate parent of Caremark. For purposes of this Opinion, reference to CVS includes Caremark. to strike the amended complaint. Rather than strike the amended complaint, at a hearing held on May 22, 2025, the Court ordered that the claims be severed so that there would be separate adversary proceedings against each defendant, and

the Debtor’s attorney was further ordered to pay the filing fee for each of the severed cases. The filing fees were paid, and the result was separate proceedings against each defendant all based on the same first amended complaint. Relevant to the present proceedings, Count I of the first amended complaint alleges that Aetna and CVS deducted DIR fees in unknown amounts from the Debtor’s accounts receivable after the petition date of January 30, 2023. Because the Debtor ceased operations on January 21, 2023, the Debtor alleges that such deductions must have been on account of prepetition claims and are

therefore avoidable under §549(a). Count I further seeks an accounting and recovery of amounts avoided under §§542(a) and 550(a). Counts II and III seek to avoid constructively fraudulent transfers to Aetna under §548(a)(1)(B) and 740 ILCS 160/5, respectively. Count II alleges that, between January 31, 2021, and January 30, 2023, “Aetna offset approximately $127,983.72 in DIR fees from [the Debtor’s] Accounts Receivable” for obligations incurred by the Debtor within that period. The Debtor alleges that it received less than a reasonably equivalent value in exchange for the “excessive” DIR fees

collected and that it was insolvent at the time or made insolvent thereby. Count II further alleges that Aetna was an insider of the Debtor as defined in the Bankruptcy Code. Count III, in turn, alleges that Aetna “offset approximately $171,595.22 in DIR fees from [the Debtor’s] Accounts Receivable” between January 31, 2019, and January 30, 2023, on account of obligations incurred by the Debtor over the same period. The Debtor alleges it received less than reasonably equivalent value for the described transfers and that the Debtor was

“(i) engaged or was about to engage in a business or a transaction for which the remaining assets of the debtor were unreasonably small in relation to the business or transaction, and/or (ii) intended to incur, or believed or reasonably should have believed that it would incur, debts beyond its ability to pay as they became due.” Counts IV and V similarly seek to avoid constructively fraudulent transfers to CVS under §548(a)(1)(B) and 740 ILCS 160/5, respectively. They make the same allegations against CVS that are set forth in Counts II and III against Aetna,

differing only in the amounts of the alleged transfers. In that regard, Count IV alleges that “CVS offset approximately $100,241.43 in DIR fees” in the two-year period ending on the petition date, and Count V alleges that “CVS offset approximately $135,087.86 in DIR fees” in the four years preceding the bankruptcy. As it happens, Aetna and CVS are represented by the same attorneys who filed substantially identical Motions to Dismiss Plaintiff’s Complaint and to Compel Arbitration in each case. The Motions to Compel Arbitration state that

they are brought pursuant to the Federal Arbitration Act and purport to reserve the Defendants’ rights to seek dismissal under Federal Rule of Civil Procedure

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Dean Witter Reynolds Inc. v. Byrd
470 U.S. 213 (Supreme Court, 1985)
Shearson/American Express Inc. v. McMahon
482 U.S. 220 (Supreme Court, 1987)
First Options of Chicago, Inc. v. Kaplan
514 U.S. 938 (Supreme Court, 1995)
Stern v. Marshall
131 S. Ct. 2594 (Supreme Court, 2011)
In re Gandy
299 F.3d 489 (Fifth Circuit, 2002)
James Hoskins v. John Poelstra
320 F.3d 761 (Seventh Circuit, 2003)
Trefny v. Bear Stearns Securities Corp.
243 B.R. 300 (S.D. Texas, 1999)
In Re Worldcom, Inc.
401 B.R. 637 (S.D. New York, 2009)
King Ex Rel. Estate of King v. Kramer
763 F.3d 635 (Seventh Circuit, 2014)
Wellness Int'l Network, Ltd. v. Sharif
575 U.S. 665 (Supreme Court, 2015)
Kirkland v. Rund (In Re EPD Investment Co.)
821 F.3d 1146 (Ninth Circuit, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
ACJK, Inc. v. AETNA HEALTH MANAGEMENT, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/acjk-inc-v-aetna-health-management-llc-ilsb-2026.